Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05917860
Title Neoadjuvant ADT With TULSA in the Treatment of Intermediate Risk Prostate Cancer (NeoADT-TULSA)
Acronym NeoADT-TULSA
Recruitment Recruiting
Gender male
Phase Phase I
Variant Requirements No
Sponsors Turku University Hospital
Indications
Therapies
Age Groups: adult | senior
Covered Countries FIN


No variant requirements are available.